Lisinopril Versus Hydrochlorothiazide in Obese Hypertensive Patients: A Multicenter Placebo-Controlled Trial

Reisin, Efrain, Weir, Matthew R., Falkner, Bonita, Hutchinson, Howard G., Anzalone, Deborah A., Hypertension, Michael L. Tuck for the Treatment in Obese Patients With·1997·Hypertension
DOI 10.1161/01.hyp.30.1.140

Cited by (157)

Items 101–157 of 157

  1. Obesity and Metabolic Syndrome Hypertension
    Michael E. Hall, Zhen Wang, Jussara Marcia do Carmo, Daisuke Kamimura, John Edward Hall · 2018 · Updates in hypertension and cardiovascular protection
  2. Recommendations for Special Populations
    Anjanette S. Tan, Saravanan Kuppuswamy, Adam T. Whaley‐Connell, L. Romayne Kurukulasuriya, James R. Sowers · 2004 · The Endocrinologist
  3. Antihypertensive therapy in the obese hypertensive patient
    Marzena Chrostowska, Radosław Szczęch, Krzysztof Narkiewicz · 2006 · Current Opinion in Nephrology & Hypertension
  4. Medical Complications of Obesity and Optimization of the Obese Patient for Colorectal Surgery
    Nell Maloney Patel, Manish S. Patel · 2011 · Clinics in Colon and Rectal Surgery
  5. Obesity-Associated Hypertension
    Gabriel Ikponmosa Uwaifo · 2012 · Humana Press eBooks
  6. Behandlung der Hypertonie bei Adipositas
    Jürgen Scholze, Arya Mitra Sharma · 2001 · Herz
  7. In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension
    John S. Clemmer, William Andrew Pruett, Robert L. Hester · 2021 · PLoS ONE
  8. Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks
    Lizzy M. Brewster, Jos Kleijnen, Gert A. van Montfrans · 2005 · Cochrane Database of Systematic Reviews · Retracted
  9. Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertension
    Brent M. Egan, Guido M. Grassi · 2013 · Journal of Hypertension
  10. 50 Years of Thiazides: Should Thiazide Diuretics Be Considered Third-Line Hypertension Treatment?
    Angela L. Brown, Becky Captain · 2010 · American Journal of Therapeutics
  11. Modern Principles of Treatment of Uncontrolled Hypertension
    Valery I. Podzolkov, Aida I. Tarzimanova, З. О. Георгадзе · 2019 · Rational Pharmacotherapy in Cardiology
  12. Optimizing blood pressure control in the obese patient
    Tobias Pischon, Arya Mitra Sharma · 2002 · Current Hypertension Reports
  13. Longitudinal Changes of Insulin Sensitivity in Essential Hypertension: Influence of Blood Pressure Control and Familial Predisposition to Hypertension
    Anna Maria Grandi, Paolo Zanzi, Roberta Broggi, Anna Fachinetti, Luigina Guasti, Luca Ceriani, Achille Venco · 2001 · The Journal of Clinical Endocrinology & Metabolism
  14. A COMPARISON OF NISOLDIPINE ER AND AMLODIPINE FOR THE TREATMENT OF MILD TO MODERATE HYPERTENSION
    Charles Whitcomb, Guido Enzmann, Harrihar A. Pershadsingh, R Johnson, Vincent T. Ciuryla, Efrain Reisin · 2000 · International Journal of Clinical Practice
  15. Angiotensin-Converting Enzyme Inhibitors, AG Receptor Blockers, and Aldosterone Receptor Antagonists
    Kyung W. Park · 2005 · International Anesthesiology Clinics
  16. Blood pressure and cardiorenal responses to antihypertensive therapy in obese women
    Eduardo Cantoni Rosa, Maria Teresa Zanella, Nárcia E. B. Kohlmann, Sandra Roberta G. Ferreira, Frida Liane Plavnik, Artur Beltrame Ribeiro, Osvaldo Kohlmann · 2008 · Arquivos Brasileiros de Endocrinologia & Metabologia
  17. Impact of Mineralocorticoid Receptor and Angiotensin II Type 1 Receptor Antagonism on Blood Pressure Regulation in Obese Zucker Rats: Role of Sex Differences
    Jussara Marcia do Carmo, Alexandre A. da Silva, John Edward Hall · 2020 · American Journal of Hypertension
  18. Pathophysiology and Optimal Management of Hypertension in Patients with Cardiometabolic Syndrome
    Sang‐Hyun Ihm · 2021 · CardioMetabolic Syndrome Journal
  19. MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
    Е. И. Асташкин, М. Г. Глезер · 2013 · CARDIOVASCULAR THERAPY AND PREVENTION
  20. Obesity Hypertension: Clinical Aspects
    Ian R. Macumber, Joseph T. Flynn · 2023 · Springer eBooks
  21. 2024 Thai guidelines on the treatment of hypertension
    Sirisawat Kunanon, Praew Kotruchin, Pairoj Chattranukulchai, Chavalit Chotruangnapa, Weranuj Roubsanthisuk, Prin Vathesatogkit, Tada Kunavisarut, Songkwan Silaruks, Sirakarn Tejavanija, Tuangsit Wataganara et al. · 2025 · Asian Biomedicine
  22. The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19
    Valery I. Podzolkov, Aida I. Tarzimanova · 2021 · Rational Pharmacotherapy in Cardiology
  23. Treatment of hypertension associated with prediabetes
    István Barna · 2009 · Orvosi Hetilap
  24. Antihypertensive Drug Therapy in Patients of African and South Asian Ethnicity: A Systematic Review
    Lizzy M. Brewster, Gert A. van Montfrans, Yackoob Kassim Seedat · 2018 · Updates in hypertension and cardiovascular protection
  25. Obesity and Hypertension
    Nikheel S. Kolatkar, Abraham Thomas, Gordon H. Williams · 2006 · Fundamental and clinical cardiology
  26. Adipose Tissue and Blood Pressure Regulation
    Lisa Ann Cassis, Sara B. Police · 2010 · Wiley eBooks
  27. Obesity, Diabetes, and Hypertension
    Anjanette S. Tan, Stephen Brietzke, David W. Gardner, James R. Sowers · 2006 · Humana Press eBooks
  28. Pharmacotherapy of Obesity and Metabolic Syndrome
    Rexford S. Ahima · 2016 · Springer eBooks
  29. Obesity and Hypertension: Etiology and the Effects of Diet, Bariatric Surgery, and Antiobesity Drugs
    Sara Elattar, Swati Chand, Amr M. Salem, Ammar Abdulfattah, Mohamed A. A. Bassiony, William H. Frishman, Wilbert S. Aronow · 2025 · Cardiology in Review
  30. Emulation of a Target Trial of Antihypertensive Medications on Weight Change
    Pi‐I D. Lin, Sheryl L. Rifas‐Shiman, Joshua Petimar, Han Yu, Matthew F. Daley, David M. Janicke, William J. Heerman, L. Charles Bailey, Carlos Maeztu, Kristina Henderson Lewis et al. · 2025 · Journal of General Internal Medicine
  31. Hypertension guidelines need to be patient oriented
    Nayanatara Nadeesha T. Tantirige, Joanna Gray, Ian B. Wilkinson · 2026 · Current Opinion in Nephrology & Hypertension
  32. Treatment strategies for obesity-related hypertension
    Efrain Reisin · 2008 · Current Hypertension Reports
  33. Pharmacotherapy of Obesity and Metabolic Syndrome
    Rexford S. Ahima · 2015 · Springer eBooks
  34. Obesity in Hypertension
    Xavier Pi-Sunyer, Panagiotis Kokkoris · 2007 · Elsevier eBooks
  35. Obesity and Hypertension: Impact on Cardiovascular and Renal Systems
    John Edward Hall, Daniel W. Jones, Jay J. Kuo, Alexandre A. da Silva, Jiankang Liu, Lakshmi S. Tallam · 2005 · Elsevier eBooks
  36. Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
    Л. И. Абасова, Р. Л. Дашдамиров, А Б Бахшалиев · 2011 · CARDIOVASCULAR THERAPY AND PREVENTION
  37. Obesity, adipokines and their relationship with insulin resistance
    Wendy A. García-Ortega, José Ángel Angulo-Camacho, Alfredo Ibarra-Sánchez · 2023 · Ciencia Latina Revista Científica Multidisciplinar
  38. Angiotensin Converting Enzyme Inhibitors and AT1 Antagonists for Treatment of Hypertension
    Carmine Morisco, Bruno Trimarco · 2014 · Springer eBooks
  39. Influence of West African Ethnicity and Gender on Beta-Cell Function and Insulin Sensitivity in Essential Hypertensives Treated with Hydrochlorothiazide and Hydrochlorothiazide-lisinopril Combination
    Micheal Olamoyegun, Babatope Ayodeji Kolawole, Adesuyi A Leslie Ajayi · 2017 · Journal of Pharmacology and Pharmacotherapeutics
  40. HYPERTENSION AND DIABETES MELLITUS TYPE 2
    Михаил Евгеньевич Стаценко, M. V. Derevyanchenko · 2018 · Rational Pharmacotherapy in Cardiology
  41. Obesity-Hypertension Physiopathology and Treatment: A Forty-Year Retrospect
    Jonathan Owen, Stephen Morse, Angela McLean, Efrain Reisin · 2018 · Updates in hypertension and cardiovascular protection
  42. Treatment of Hypertension: Is There a Place for Personalization of the Approach in Modern Recommendations?
    Valery I. Podzolkov, Anna E. Bragina, Yu. N. Rodionova · 2020 · Rational Pharmacotherapy in Cardiology
  43. Azilsartan medoxomil for improving insulin resistance and adipokine levels in hypertension in comparison with angiotensin-converting enzyme inhibitors
    Sergey Vladimirovich Nedogoda, Elena V. Chumachek, В. В. Цома, Т Н Санина, Alla Sergeevna Salasyuk, В. О. Смирнова, Ekaterina Andreevna Popova · 2020 · Russian Journal of Cardiology
  44. Postoperative Care of the Obese Patient
    Hui Sen Chong, Robert L. Bell · 2012
  45. Neural mechanisms of sympathetic activation during hyperinsulinemia and obesity-induced hypertension
    Megan Elyse Bardgett · 2010 · UKnowledge (University of Kentucky)
  46. Impact of ALLHAT on the Role of Angiotensin-Converting Enzyme Inhibitors in the Primary Prevention of Heart Failure
    Ali Ahmed · 2004 · Annals of Internal Medicine
  47. Treatment of Isolated Systolic Hypertensive Disease without Complications in the Wards of the Psycho-Neurological Nursing Home
    N. V. Gutareva, E. E. Yablochanska, V. V. Gutarev · 2018 · Ukraïnsʹkij žurnal medicini bìologìï ta sportu
  48. Obesity
    Arya Mitra Sharma · 2002
  49. Obesity in Hypertension
    Xavier Pi-Sunyer, Panagiotis Kokkoris, Ignatius M.Y. Szeto · 2012 · Elsevier eBooks
  50. Vozmozhnost' korrektsii Ravelom SR faktorov riska pri arterial'noy gipertenzii na fone ozhireniya
    Sergey Vladimirovich Nedogoda, Irina Nikolaevna Barykina, U. A. Brel, Чаляби Татьяна Азизовна · 2007 · Systemic Hypertension
  51. Obesity Hypertension: Clinical Aspects
    Ian R. Macumber, Joseph T. Flynn · 2022 · Springer eBooks
  52. Clinical Efficacy of Combined Use of Azilsartan with Indapamide and Azilsartan with Nitrendipine in Patients with Arterial Hypertension
    Zarina Mashkurova, Г. Ж. Абдуллаева, G Khamidullaeva, Nigora Sherbadalova, M Khatamova, Ж Сафаров, Munisa Atoeva · 2022 · International Journal of Biomedicine
  53. Miejsce lisinoprilu w nowoczesnej kardiologii
    Anna Szyndler, Piotr Dobrowolski, Andrzej Januszewicz, Artur Mamcarz, Krzysztof Narkiewicz, Aleksander Prejbisz, Andrzej Tykarski, Jacek Wolf · 2023 · Choroby Serca i Naczyń
  54. Etudes des effets cardio-métaboliques d'une aminopyrroline sympatho-inhibitrice dans un modèle de syndrome métabolique chez le primate non humain : mise en évidence des mécanismes d’action impliqués
    Maud Weiss · 2016 · theses.fr (ABES)
  55. Drug‑induced weight gain: pathophysiological mechanisms, clinically relevant drug classes, and management strategies
    Tatyana Nikolaevna Skobeleva, M. Yu. Savgacheva, D. A. Karakchiev · 2026 · Patient-Oriented Medicine and Pharmacy
  56. CQ essential hypertension classification: The comprehensive classification to facilitate precise therapy
    Ken Chen, Chunyu Zeng · 2026 · Clinical and Experimental Hypertension
  57. Impact of use of antihypertensive drugs on resting energy expenditure and body composition: A matched-pair analysis of users and non-users
    S Ramminger, Jens-Peter Keil, Klara Jadrna, Michael T Koller, Caroline M. KISS, Luzia Valentini · 2026 · Clinical Nutrition ESPEN